According to a study, scientists from pharmaceutical trade publish a higher fraction of their papers open access than academics who aren’t in industry. The open-access papers published by 23 large drug companies, such as Pfizer and Roche has overtaken the quantity of liberally available papers published most prominently in medicine-related fields.“It seems like big pharma has a notable niche in open access,” says Kyle Siler, a social scientist at Utrecht University in the Netherlands.
Related Posts
Male Mouse Cells Used to Create Viable Eggs and Offspring
Scientists have created viable eggs from the cells of male mice using a new approach, according to findings presented at the Third International Summit on Human Genome Editing in London. The eggs, which were fertilized using mouse sperm and implanted into female mice, produced healthy, fertile offspring, although only seven out of 630 transferred embryos […]
Assessing the Japanese Bamboo’s Antibacterial Properties
Assessing the antibacterial properties of Japanese Bamboo involves conducting comprehensive studies to evaluate its effectiveness in inhibiting or killing bacteria. Researchers typically employ various methodologies, such as laboratory tests and experiments, to assess the antibacterial activity of compounds found in Japanese Bamboo. This assessment may involve using bacterial cultures and measuring the inhibition zones or […]
De Gruyter to Digitally Archive 40,000 books by 2020
De Gruyter plans to digitize the entirety of its backlist from 1749. The final De Gruyter Book Archive will contain almost 40,000 titles, which will be available as ebooks and high-quality hardcover printed on-demand PODs. Reference Link: https://www.degruyter.com/dg/newsitem/231/de-gruyter-book-archive-260-jahre-verlagsgeschichte-digital Share via: Facebook X (Twitter) LinkedIn More